Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Potlatch Appoints Eric Cremers As EVP, CFO - Quick Facts

RELATED NEWS
Trade PCH now with 

Potlatch Corp. (PCH: Quote) announced that it has named Eric Cremers executive vice president or EVP and chief financial officer or CFO, effective March 1, 2012.

In addition to his current role as chief financial officer, Cremers will assume responsibility for management of the company's timberlands in Idaho as well as responsibilities for harvest scheduling, science and technology support company-wide, the company stated.

These organizational changes are being implemented in advance of Brent Stinnett's planned retirement at year-end as the vice president, resource management.

Commenting on Cremers, Potlatch said he joined Potlatch in 2007 as vice president finance and chief financial officer after working for Albertsons as senior vice president, corporate strategy and business development. Prior to that, Cremers was managing director, investment banking for Piper Jaffray.

Click here to receive FREE breaking news email alerts for Potlatch Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After showing a notable move to the upside in early trading on Tuesday, stocks showed a substantial downturn over the course of the session. Concerns about the impact of new sanctions against Russia weighed on the markets. A day after lawmakers announced an agreement on compromise legislation to reform the Veterans Affairs Department, the Senate voted unanimously Tuesday to confirm a new head of the scandal-plagued department. Looking to increase pressure on Congress, the White House released a report on Tuesday warning of the economic costs of delaying action to address climate change.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.